Literature DB >> 15310476

Sleep, cytokines and immune function.

J B Dickstein1, H Moldofsky.   

Abstract

Bi-directional communication pathways exist between the brain and the cytokine-immune-endocrine systems. The hypothalamic-pituitary axis, the efferent neuronal hypothalamus-autonomic nervous system axis, and the direct drainage of macromolecules from the brain into the blood and the lymphatic system provide a network by which the sleeping/waking brain influence bodily functions. Similarly, changes in cytokine levels in the periphery modulate the central nervous system either directly or via the vagal nerve and influence the sleeping/waking brain. In humans, circadian nocturnal sleep-daytime wakefulness is associated with changes in peripheral cytokines, cellular immune functions, and endocrines. Progesterone levels influence sleep and cellular immune functions during the menstrual cycle. The interaction between the circadian sleeping/waking brain and the cytokine-immune-endocrine system are integral to preserving homeostasis. Disorganization or loss of sleep disrupts the harmonious integration of the circadian cytokine-immune-endocrine system. However, the mechanisms of circadian sleep/wakefulness-related cytokine-immune-endocrine functions in host defence against disease remain to be determined.

Entities:  

Year:  1999        PMID: 15310476     DOI: 10.1016/s1087-0792(99)90003-5

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  9 in total

1.  No effect of a 30-h period of sleep deprivation on leukocyte trafficking, neutrophil degranulation and saliva IgA responses to exercise.

Authors:  J S Costa Ricardo; Louise Cartner; Samuel J Oliver; Stewart J Laing; Robert Walters; James L J Bilzon; Neil P Walsh
Journal:  Eur J Appl Physiol       Date:  2008-11-19       Impact factor: 3.078

2.  Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation.

Authors:  Jami A Kinnucan; David T Rubin; Tauseef Ali
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-11

Review 3.  Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Owais Bhatti; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

4.  Development and Validation of the Immune Status Questionnaire (ISQ).

Authors:  Livia J F Wilod Versprille; Aurora J A E van de Loo; Marlou Mackus; Lizanne Arnoldy; Titia A L Sulzer; Sterre A Vermeulen; Smedra Abdulahad; Hendrikje Huls; Ton Baars; Andrew Scholey; Aletta D Kraneveld; Johan Garssen; Joris C Verster
Journal:  Int J Environ Res Public Health       Date:  2019-11-27       Impact factor: 3.390

5.  Traumatic Brain Injury Characteristics Predictive of Subsequent Sleep-Wake Disturbances in Pediatric Patients.

Authors:  Brittany Gerald; J Bryce Ortiz; Tabitha R F Green; S Danielle Brown; P David Adelson; Sean M Murphy; Rachel K Rowe
Journal:  Biology (Basel)       Date:  2022-04-14

6.  The inflammatory immune system after wake up in healthy male individuals: A highly standardized and controlled study.

Authors:  Katja Petrowski; Bjarne Schmalbach; Mona Linhardt; Liza Mekschrat; Nicolas Rohleder
Journal:  Brain Behav Immun Health       Date:  2022-08-28

7.  Microglia Are Necessary to Regulate Sleep after an Immune Challenge.

Authors:  Rachel K Rowe; Tabitha R F Green; Katherine R Giordano; J Bryce Ortiz; Sean M Murphy; Mark R Opp
Journal:  Biology (Basel)       Date:  2022-08-19

Review 8.  COVID-19: Sleep, Circadian Rhythms and Immunity - Repurposing Drugs and Chronotherapeutics for SARS-CoV-2.

Authors:  Allan Giri; Ashokkumar Srinivasan; Isaac Kirubakaran Sundar
Journal:  Front Neurosci       Date:  2021-06-18       Impact factor: 4.677

9.  The association of the quality of sleep with proinflammatory cytokine profile in inflammatory bowel disease patients.

Authors:  Aleksandra Sobolewska-Włodarczyk; Marcin Włodarczyk; Marcin Talar; Maria Wiśniewska-Jarosińska; Anita Gąsiorowska; Jakub Fichna
Journal:  Pharmacol Rep       Date:  2021-10-25       Impact factor: 3.024

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.